WT1 and FOXA1 silencing impaired the tumor-sphere forming ability of neurospheres treated with TMZ (Fig. 4F), decreased the spheroid frequency and reduced the mRNA expression of the stem markers NANOG, OCT4 and SOX2 (Fig. 4Gleft and right panels). The gene discussed is WT1; the disease is neoplasm.